8 November 2019 | Absence of islet autoantibodies and modestly raised glucose values at diabetes diagnosis should lead to testing for MODY: Lessons from a 5-year pediatric Swedish national cohort study | Carlsson, A; Shepherd, M; Ellard, S; et al. |
18 November 2010 | Integrated genetic and epigenetic analysis identifies haplotype-specific methylation in the FTO type 2 diabetes and obesity susceptibility locus | Bell, CG; Finer, S; Lindgren, CM; et al. |
13 June 2018 | Permanent neonatal diabetes: combining sulfonylureas with insulin may be an effective treatment. | Misra, S; Vedovato, N; Cliff, E; et al. |
16 January 2013 | Biallelic PDX1 (insulin promoter factor 1) mutations causing neonatal diabetes without exocrine pancreatic insufficiency | De Franco, E; Shaw-Smith, C; Flanagan, SE; et al. |
6 December 2012 | GATA6 mutations cause a broad phenotypic spectrum of diabetes from pancreatic agenesis to adult-onset diabetes without exocrine insufficiency | De Franco, E; Shaw-Smith, C; Flanagan, SE; et al. |
28 September 2016 | Genome-wide associations for birth weight and correlations with adult disease | Horikoshi, M; Beaumont, RN; Day, FR; et al. |
12 June 2018 | The Common HNF1A Variant I27L is a Modifier of Age at Diabetes Diagnosis in HNF1A-MODY Individuals. | Locke, JM; Saint-Martin, C; Laver, TW; et al. |
18 September 2018 | A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin | Shepherd, MH; Shields, BM; Hudson, M; et al. |
18 April 2019 | A specific CNOT1 mutation results in a novel syndrome of pancreatic agenesis and holoprosencephaly through impaired pancreatic and neurological development | De Franco, E; Watson, RA; Weninger, WJ; et al. |
20 August 2019 | Clusters provide a better holistic view of type 2 diabetes than simple clinical features – Authors' reply | Dennis, JM; Shields, BM; Henley, WE; et al. |